BRD4 and neoplasm: Our finding that BRD4 expression is elevated in a fraction of adjacent non-tumor liver tissue, albeit to a lesser extent than in tumor tissue, raises a potential concern for the future clinical utility of BRD4 inhibitors in human HCC, as improper drug use may cause liver damage.